Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 16:45:44 UTC |
---|
Update Date | 2021-09-26 23:11:59 UTC |
---|
HMDB ID | HMDB0256374 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid |
---|
Description | 2-{[hydroxy(5-hydroxy-3,4-dihydro-2H-pyrrol-2-yl)methylidene]amino}-3-(4H-imidazol-4-yl)propanoic acid belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. Based on a literature review very few articles have been published on 2-{[hydroxy(5-hydroxy-3,4-dihydro-2H-pyrrol-2-yl)methylidene]amino}-3-(4H-imidazol-4-yl)propanoic acid. This compound has been identified in human blood as reported by (PMID: 31557052 ). (2s)-3-(4h-imidazol-4-yl)-2-[[(2s)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | OC(=O)C(CC1C=NC=N1)NC(=O)C1CCC(=O)N1 InChI=1S/C11H14N4O4/c16-9-2-1-7(14-9)10(17)15-8(11(18)19)3-6-4-12-5-13-6/h4-8H,1-3H2,(H,14,16)(H,15,17)(H,18,19) |
---|
Synonyms | Value | Source |
---|
2-{[hydroxy(5-hydroxy-3,4-dihydro-2H-pyrrol-2-yl)methylidene]amino}-3-(4H-imidazol-4-yl)propanoate | Generator | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoate | Generator |
|
---|
Chemical Formula | C11H14N4O4 |
---|
Average Molecular Weight | 266.257 |
---|
Monoisotopic Molecular Weight | 266.101504947 |
---|
IUPAC Name | 3-(4H-imidazol-4-yl)-2-[(5-oxopyrrolidin-2-yl)formamido]propanoic acid |
---|
Traditional Name | 3-(4H-imidazol-4-yl)-2-[(5-oxopyrrolidin-2-yl)formamido]propanoic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | OC(=O)C(CC1C=NC=N1)NC(=O)C1CCC(=O)N1 |
---|
InChI Identifier | InChI=1S/C11H14N4O4/c16-9-2-1-7(14-9)10(17)15-8(11(18)19)3-6-4-12-5-13-6/h4-8H,1-3H2,(H,14,16)(H,15,17)(H,18,19) |
---|
InChI Key | DDQCRHMAPMBAFL-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dipeptides. These are organic compounds containing a sequence of exactly two alpha-amino acids joined by a peptide bond. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Dipeptides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-dipeptide
- N-acyl-alpha-amino acid
- Proline or derivatives
- N-acyl-alpha amino acid or derivatives
- Alpha-amino acid amide
- Alpha-amino acid or derivatives
- Imidazolyl carboxylic acid derivative
- Pyrrolidine carboxylic acid or derivatives
- Pyrrolidine-2-carboxamide
- 2-pyrrolidone
- Pyrrolidone
- Pyrrolidine
- Imidazole
- Secondary carboxylic acid amide
- Carboxamide group
- Lactam
- Propargyl-type 1,3-dipolar organic compound
- Azacycle
- Organoheterocyclic compound
- Organic 1,3-dipolar compound
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organonitrogen compound
- Carbonyl group
- Organooxygen compound
- Organic nitrogen compound
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
(2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)C(CC1C=NC=N1)N(C(=O)C1CCC(=O)N1)[Si](C)(C)C | 2740.3 | Semi standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)C(CC1C=NC=N1)N(C(=O)C1CCC(=O)N1)[Si](C)(C)C | 2463.7 | Standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TMS,isomer #1 | C[Si](C)(C)OC(=O)C(CC1C=NC=N1)N(C(=O)C1CCC(=O)N1)[Si](C)(C)C | 4655.2 | Standard polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TMS,isomer #2 | C[Si](C)(C)OC(=O)C(CC1C=NC=N1)NC(=O)C1CCC(=O)N1[Si](C)(C)C | 2661.0 | Semi standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TMS,isomer #2 | C[Si](C)(C)OC(=O)C(CC1C=NC=N1)NC(=O)C1CCC(=O)N1[Si](C)(C)C | 2446.2 | Standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TMS,isomer #2 | C[Si](C)(C)OC(=O)C(CC1C=NC=N1)NC(=O)C1CCC(=O)N1[Si](C)(C)C | 4483.9 | Standard polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TMS,isomer #3 | C[Si](C)(C)N1C(=O)CCC1C(=O)N(C(CC1C=NC=N1)C(=O)O)[Si](C)(C)C | 2638.6 | Semi standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TMS,isomer #3 | C[Si](C)(C)N1C(=O)CCC1C(=O)N(C(CC1C=NC=N1)C(=O)O)[Si](C)(C)C | 2492.1 | Standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TMS,isomer #3 | C[Si](C)(C)N1C(=O)CCC1C(=O)N(C(CC1C=NC=N1)C(=O)O)[Si](C)(C)C | 4503.3 | Standard polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)C(CC1C=NC=N1)N(C(=O)C1CCC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 2624.7 | Semi standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)C(CC1C=NC=N1)N(C(=O)C1CCC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 2511.5 | Standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,3TMS,isomer #1 | C[Si](C)(C)OC(=O)C(CC1C=NC=N1)N(C(=O)C1CCC(=O)N1[Si](C)(C)C)[Si](C)(C)C | 4322.5 | Standard polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1C=NC=N1)N(C(=O)C1CCC(=O)N1)[Si](C)(C)C(C)(C)C | 3168.2 | Semi standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1C=NC=N1)N(C(=O)C1CCC(=O)N1)[Si](C)(C)C(C)(C)C | 2895.0 | Standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1C=NC=N1)N(C(=O)C1CCC(=O)N1)[Si](C)(C)C(C)(C)C | 4770.8 | Standard polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1C=NC=N1)NC(=O)C1CCC(=O)N1[Si](C)(C)C(C)(C)C | 3135.8 | Semi standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1C=NC=N1)NC(=O)C1CCC(=O)N1[Si](C)(C)C(C)(C)C | 2889.8 | Standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1C=NC=N1)NC(=O)C1CCC(=O)N1[Si](C)(C)C(C)(C)C | 4645.8 | Standard polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(=O)CCC1C(=O)N(C(CC1C=NC=N1)C(=O)O)[Si](C)(C)C(C)(C)C | 3097.6 | Semi standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(=O)CCC1C(=O)N(C(CC1C=NC=N1)C(=O)O)[Si](C)(C)C(C)(C)C | 2915.2 | Standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,2TBDMS,isomer #3 | CC(C)(C)[Si](C)(C)N1C(=O)CCC1C(=O)N(C(CC1C=NC=N1)C(=O)O)[Si](C)(C)C(C)(C)C | 4647.2 | Standard polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1C=NC=N1)N(C(=O)C1CCC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3234.4 | Semi standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1C=NC=N1)N(C(=O)C1CCC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3125.9 | Standard non polar | 33892256 | (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(=O)C(CC1C=NC=N1)N(C(=O)C1CCC(=O)N1[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 4494.2 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-9210000000-dc91629320d03d429271 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (2S)-3-(4H-Imidazol-4-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-10-25 | Wishart Lab | View Spectrum |
|
---|